<DOC>
	<DOCNO>NCT01889888</DOCNO>
	<brief_summary>Autologous adipose-derived regenerative cell ( ADRC ) extract use Celution 800/CRS System ( Cytori Therapeutics Inc ) portion fat harvest patient 's front abdominal wall . ADRC administer one-time endoscopically submucosal layer urethra eye control stricture site mechanical dilation . This single arm study control . All patient receive cell therapy .</brief_summary>
	<brief_title>Effectiveness Safety Autologous Adipose-Derived Regenerative Cells Treatment Urethral Strictures</brief_title>
	<detailed_description>Fat tissue obtainment . Subjects undergo liposuction local anesthesia . In procedure , Ringer 's solution anesthetic lidocaine vasoconstrictor adrenaline infuse adipose compartment minimize blood loss contamination tissue peripheral blood cell . 15 minute later hollow blunt-tipped 3 mm cannula introduce subcutaneous space small ( 0.5 cm ) incision . The cannula attach syringe gentle suction move adipose compartment , mechanically disrupt fat tissue . Aspirate volume - approximately 150-200 cc . Procedure time - 30 minute . ADRC isolation . Aspirated fat tissue place sterile vessel insert Celution 800/CRS System ( Cytori Therapeutics Inc ) - closed system automate standardized extraction concentration ADRC . Celution 800/CRS System drain excess fluid fat tissue estimate 's volume After lipoaspirate wash extensively equal volume Ringer 's solution remove blood . At end process System indicate require volume enzyme reagent ( Celase® ) add immediately operator . After enzyme treatment Celution 800/CRS System automatically transfer isolate ADRC wash compartment ADRC wash concentrate 5 mL suspension . Tissue processing time - approximately 60 minute . ADRC suspension match requirement list technical documentation Celution 800/CRS System . Obtained ADRC divide 2 portion . First portion ( 0.2-0.5 mL ) use counting , viability sterility assessment . Second portion place sterile syringe injection . Urethral stricture dilation . Under direct vision HiWire® hydrophilic nitinol wire position urethra exchange stiff-bodied wire . After S-Curve urethral dilator ( Cook Medical Inc. ) pass wire guide progress smallest large 24 ( Fr ) appropriate size maintaining wire guide 's position . Periurethral injection ADRC . After dilation needle injection introduce urethra use endoscope . Urethra puncture several time circle-wise region stricture depth 5 mm endoscopic vision 0.3-0.5 mL ADRC suspension inject submucosally time . Total volume solution inject depend stricture length technical possibility . Minimal inject volume - 3 mL , maximal - 4.5 ml . After fat micrograft inject , urethral balloon catheter place removed following day .</detailed_description>
	<mesh_term>Constriction , Pathologic</mesh_term>
	<mesh_term>Urethral Stricture</mesh_term>
	<criteria>Patient suffers urethral stricture least 1 year Moderate severe grade obstructive voiding symptom accord assessment make investigator Patient familiar Participant information sheet . Patient sign informed consent form Contraindications local anesthesia For patient undergone surgical treatment prostate cancer : Cancer relapse prostatespecific antigen ( PSA ) level &gt; 0.008 ng/mL</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Male urethral stricture</keyword>
	<keyword>ADRC</keyword>
	<keyword>Adipose-derived regenerative cell</keyword>
	<keyword>Fat tissue</keyword>
	<keyword>Stem cell</keyword>
</DOC>